LFMD Quote, Financials, Valuation and Earnings

Eli Lilly & Co. has a net margin of -2.32% compared to LifeMD, Inc.'s net margin of 34.4%. LifeMD, Inc.'s return on equity of -113.32% beat Eli Lilly & Co.'s return on equity of 104.39%.

LifeMD, Inc. has a consensus price target of $9.88, signalling upside risk potential of 181.34%. On the other hand Eli Lilly & Co. has an analysts' consensus of $1,209.21 which suggests that it could grow by 29.25%. Given that LifeMD, Inc. has higher upside potential than Eli Lilly & Co., analysts believe LifeMD, Inc. is more attractive than Eli Lilly & Co..

LifeMD, Inc. has a beta of 1.771, which suggesting that the stock is 77.092% more volatile than S&P 500. In comparison Eli Lilly & Co. has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.45%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Eli Lilly & Co. offers a yield of 0.68% to investors and pays a quarterly dividend of $1.73 per share. LifeMD, Inc. pays -- of its earnings as a dividend. Eli Lilly & Co. pays out 26.14% of its earnings as a dividend. Eli Lilly & Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $46.9M, which are smaller than Eli Lilly & Co. quarterly revenues of $19.3B. LifeMD, Inc.'s net income of -$1.1M is lower than Eli Lilly & Co.'s net income of $6.6B. Notably, LifeMD, Inc.'s price-to-earnings ratio is 15.63x while Eli Lilly & Co.'s PE ratio is 40.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.67x versus 12.82x for Eli Lilly & Co.. Usually stocks with elevated PS ratios are considered overvalued.

Veradigm, Inc. has a net margin of -2.32% compared to LifeMD, Inc.'s net margin of --. LifeMD, Inc.'s return on equity of -113.32% beat Veradigm, Inc.'s return on equity of --.

LifeMD, Inc. has a consensus price target of $9.88, signalling upside risk potential of 181.34%. On the other hand Veradigm, Inc. has an analysts' consensus of $5.83 which suggests that it could grow by 26.81%. Given that LifeMD, Inc. has higher upside potential than Veradigm, Inc., analysts believe LifeMD, Inc. is more attractive than Veradigm, Inc..

LifeMD, Inc. has a beta of 1.771, which suggesting that the stock is 77.092% more volatile than S&P 500. In comparison Veradigm, Inc. has a beta of 0.555, suggesting its less volatile than the S&P 500 by 44.461%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veradigm, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays -- of its earnings as a dividend. Veradigm, Inc. pays out -- of its earnings as a dividend.

LifeMD, Inc. quarterly revenues are $46.9M, which are larger than Veradigm, Inc. quarterly revenues of --. LifeMD, Inc.'s net income of -$1.1M is higher than Veradigm, Inc.'s net income of --. Notably, LifeMD, Inc.'s price-to-earnings ratio is 15.63x while Veradigm, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.67x versus 0.85x for Veradigm, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

TruBridge, Inc. has a net margin of -2.32% compared to LifeMD, Inc.'s net margin of 6.3%. LifeMD, Inc.'s return on equity of -113.32% beat TruBridge, Inc.'s return on equity of 1.61%.

LifeMD, Inc. has a consensus price target of $9.88, signalling upside risk potential of 181.34%. On the other hand TruBridge, Inc. has an analysts' consensus of $21.33 which suggests that it could grow by 31.36%. Given that LifeMD, Inc. has higher upside potential than TruBridge, Inc., analysts believe LifeMD, Inc. is more attractive than TruBridge, Inc..

LifeMD, Inc. has a beta of 1.771, which suggesting that the stock is 77.092% more volatile than S&P 500. In comparison TruBridge, Inc. has a beta of 0.753, suggesting its less volatile than the S&P 500 by 24.742%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TruBridge, Inc. offers a yield of 2.39% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays -- of its earnings as a dividend. TruBridge, Inc. pays out -- of its earnings as a dividend.

LifeMD, Inc. quarterly revenues are $46.9M, which are smaller than TruBridge, Inc. quarterly revenues of $86.1M. LifeMD, Inc.'s net income of -$1.1M is lower than TruBridge, Inc.'s net income of $5.4M. Notably, LifeMD, Inc.'s price-to-earnings ratio is 15.63x while TruBridge, Inc.'s PE ratio is 54.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.67x versus 0.68x for TruBridge, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

WW International has a net margin of -2.32% compared to LifeMD, Inc.'s net margin of -38.91%. LifeMD, Inc.'s return on equity of -113.32% beat WW International's return on equity of --.

LifeMD, Inc. has a consensus price target of $9.88, signalling upside risk potential of 181.34%. On the other hand WW International has an analysts' consensus of $1.10 which suggests that it could grow by 340.71%. Given that WW International has higher upside potential than LifeMD, Inc., analysts believe WW International is more attractive than LifeMD, Inc..

LifeMD, Inc. has a beta of 1.771, which suggesting that the stock is 77.092% more volatile than S&P 500. In comparison WW International has a beta of 1.298, suggesting its more volatile than the S&P 500 by 29.755%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WW International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays -- of its earnings as a dividend. WW International pays out -- of its earnings as a dividend.

LifeMD, Inc. quarterly revenues are $46.9M, which are smaller than WW International quarterly revenues of $186.6M. LifeMD, Inc.'s net income of -$1.1M is higher than WW International's net income of -$72.6M. Notably, LifeMD, Inc.'s price-to-earnings ratio is 15.63x while WW International's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.67x versus 0.03x for WW International. Usually stocks with elevated PS ratios are considered overvalued.